ReviewInternational journal of molecular medicine2023

Inhibitors of the NLRP3 inflammasome pathway as promising therapeutic candidates for inflammatory diseases (Review).

Xiaolu Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.